Blauw GJ, Lagaay AM, Smelt AH. Stroke, statins and cholesterol: a meta-analysis of randomized, placebo-controlled, double-blind trials with HMG-CoA reductase inhibitors. Stroke. 1997;28:946-50.

Dormandy J, Heeck L, Vig S. Predictors of early disease in the lower limbs. Semin Vasc Surg. 1997;12:109-17.

Folkman J. Tumor angiogenesis: therapeutic implications. N Engl J Med. 1971;285:1182-6.

Takeshita S, Zheng LP, Brogi E. Therapeutic angiogenesis: A single intraarterial bolus of vascular endothelial growth factor augments revascularization in a rabbit ischemic hind limb model. J Clin Invest. 1994;93:662-70.

Isner JM, Pieczek A, Schainfeld R. Clinical evidence of angiogenesis after arterial gene transfer of phVEGF165 in patient with ischaemic limb. Lancet. 1996;348:370-4.

Murohara T, Asahara T, Silver M. Nitric oxide synthase modulates angiogenesis in response to tissue ischemia. J Clin Invest. 1998;101:2567-7.

Asahara T, Murohara T, Sullivan A. Isolation of putative progenitor endothelial cells for angiogenesis. Science. 1997;275:964-7.

Shi Q, Rafii S, Hong-De Wu. Evidence for circulating bone marrow-derived endothelial cells. Blood. 1998;92:362-7.

Bhattacharya V, Peter A, Shi Q. Enhanced endothelialization and microvessel formation in polyester grafts seeded with CD34+ bone marrow cells. Blood. 2000;95:581-5.

Asahara T, Masuda H, Takahashi T. Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization. Circ Res. 1999;85:221-8.

Ikenaga S, Hamano K, Nishida M. Autologous bone marrow implantation induced angiogenesis and improved deteriorated exercise capacity in a rat ischemic hindlimb model. J Surg Res. 2001;96:277-83.

Hirata K, Li TS, Nishida M. Autologous bone marrow cell implantation as therapeutic angiogenesis for ischemic hindlimb in diabetic rat model. Am J Physiol Heart Circ Physiol. 2003;284:H 66-70.

Losordo DW, Vale PR, Hendel RC. Phase 1/2 placebo-controlled, double-blind, dose-escalating trial of myocardial vascular endothelial growth factor 2 gene transfer by catheter delivery in patients with chronic myocardial ischemia. Circulation. 2002;105:2012-18.

Buschmann I, Schaper W. The pathophysiology of the collateral circulation (arteriogenesis). J Pathol. ;190:338-42.

Kalka C, Tehrani H, Laudenberg B. VEGF gene transfer mobilizes endothelial progenitor cells in patients with inoperable coronary disease. Ann Thorac Surg. 2000;70:829-34.

Hamano K, Li TS, Kobayashi T. Therapeutic angiogenesis induced by local autologous bone marrow cell implantation. Ann Thorac Surg. 2002;73:1210-5.

Grines CL, Watkins MW, Helmer G. Angiogenic Gene Therapy (AGENT) Trial in patients with stable angina pectoris. Circulation. 2002;105:1291-7.

Heeschen C, Lehmann R, Honold J. Profoundly reduced neovascularization capacity of bone marrow mononuclear cells derived from patients with chronic ischemic heart disease. Circulation. 2004;109:1615-22.

Lederman R, Tenaglia A, Anderson R. Design of the therapeutic angiogenesis with recombinant fibroblast growth factor-2 for intermittent claudication (TRAFFIC) trial. AJC. 2001;88:192-5.

Iba O, Hiroaki M, Yoshihisa N. Angiogenesis by implantation of peripheral blood mononuclear cells and platelets into ischemic lim. Circulation. 2002;106:2019-25.

Al-Khaldi A, Al-Sabti H, Galipeau J. Therapeutic angiogenesis using autologous bone marrow stromal cells: improved blood flow in a chronic limb ischemia model. Ann Thorac Surg. 2003;75:204-9.

Kinnaird T, Stabile E, Burnett MS. Marrow-derived stromal cells express genes encoding a broad spectrum of arteriogenic cytokines and promote in vitro and in vivo arteriogenesis though paracrine mechanisms. Circ Res. 2004;94:678-85.

Tateishi-Yuyama E, Matsubara H, Murohara T. Therapeutic angiogenesis for patients with limb ischaemia by autologous transplantation of bone marrow cell: a pilot study and a randomised controlled trial. Lancet. 2002;360:427-35.

Kinnaird T, Stabile E, Burnett MS. Local delivery of marrow-derived stromal cells augments collateral perfusion though paracrine mechanisms. Circulation. 2004;109:1543-9.

Assmus B, Schächinger V, Teupe C. Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction (TOPCARE-AMI). Circulation. 2002;106:r23-61.

Perin EC, Dohmann HF, Borojevic R. Transendocardial, autologous bone marrow cell transplantation for severe, chronic ischemic heart failure. Circulation. 2003;107:2294-302.

Baumgartner I, Pieczek A, Manor O. Constitutive expression of ph VEGF 165 after intramuscular gene transfer promotes collateral vessel development in patients with critical limb ischemia. Circulation. 1998;97:1114-23.